United States: Interchangeable Biosimilars Have Arrived In The U.S. - Kramer Levin Naftalis & Frankel LLP
On July 28, 2021, the Food and Drug Administration (FDA) approved the first interchangeable biosimilar product...
Full Article
United States: Interchangeable Biosimilars Have Arrived In The U.S. - Kramer Levin Naftalis & Frankel LLP
Mondaq
0 shares
1 views
You might like
Related news coverage
United States: Federal Privacy Bill Aims To Consolidate US Privacy Law Patchwork - Kramer Levin Naftalis & Frankel LLP
On April 7, 2024, Sen. Maria Cantwell, chair of the Senate Commerce Committee, and Rep. Cathy McMorris Rodgers, chair of the House..
Mondaq
United States: State Budget Approves Elimination Of 12 FAR Cap In New York City - Kramer Levin Naftalis & Frankel LLP
The New York State FY 2025 budget legislation enacted on April 20th included an important and long-awaited housing reform for New..
Mondaq